Gidazepam
From Wikipedia, the free encyclopedia
|
Gidazepam
|
|
| Systematic (IUPAC) name | |
| 2-(9-bromo-3-oxo-6-phenyl-2,5-diazabicyclo[5.4.0] undeca-5,8,10,12-tetraen-2-yl)acetohydrazide |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H15BrN4O2 |
| Mol. mass | 387.2 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Gidazepam is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
|
|||||||||||||||||||||||||||||

